| Execution period | FY 2026-27 to FY 2030-31 |
|---|
BSE filing, NSE: ACEVECTOR. Summary written from the filing by ALFA Finder's alert engine.
AceVector Ltd: key numbers
- Share price
- ₹19.70
- Market cap
- ₹1,072 Cr
- Revenue (annual)
- ₹510.4 Cr
- Net profit (annual)
- ₹-60.78 Cr
- Promoter holding
- 49.96%
- FII holding
- 18.96%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AceVector Ltd
All →AceVector Earnings Call Transcript: Key Takeaways
Acevector transitions through seasonal shifts, focusing on AI-driven value fashion for Gen Z.
- Call
- Guides 20% growth
AceVector Results Update
AceVector reported H1 FY27 revenue of ₹285.5 crore, up 17%, with an adjusted EBITDA loss of ₹26.9 crore. This is a press release, not a results statement.
AceVector Investor Presentation: Key Takeaways
H1 FY27 consolidated revenue ₹285.5 Cr, up 17% YoY, with adjusted EBITDA loss of ₹26.9 Cr from Snapdeal marketing and logistics costs and Unicommerce investment.
- Call
- Guides 400% growth
AceVector Management Change
AceVector's Company Secretary Prabhas Singh resigned effective 26 Oct 2026, replaced by Madhvendra Shukla. Akhil Kumar Gupta moves to Additional Non-Executive Director.
AceVector Q2 FY27 Results: Net Loss of ₹17.6 Cr, Loss Widens
AceVector Ltd reported revenue from operations of ₹151.2 Cr (+16.9% YoY) and a net loss of ₹17.6 Cr for Q2 FY27.
- Key figure
- Net loss ₹17.6 Cr
AceVector Board Meeting Date
AceVector Ltd scheduled a board meeting on October 26, 2026, to approve standalone and consolidated financial results for quarters ending June 30 and September 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.